Literature DB >> 29429824

The Polyploid State Plays a Tumor-Suppressive Role in the Liver.

Shuyuan Zhang1, Kejin Zhou2, Xin Luo3, Lin Li1, Ho-Chou Tu4, Alfica Sehgal4, Liem H Nguyen1, Yu Zhang1, Purva Gopal5, Branden D Tarlow1, Daniel J Siegwart2, Hao Zhu6.   

Abstract

Most cells in the liver are polyploid, but the functional role of polyploidy is unknown. Polyploidization occurs through cytokinesis failure and endoreduplication around the time of weaning. To interrogate polyploidy while avoiding irreversible manipulations of essential cell-cycle genes, we developed orthogonal mouse models to transiently and potently alter liver ploidy. Premature weaning, as well as knockdown of E2f8 or Anln, allowed us to toggle between diploid and polyploid states. While there was no detectable impact of ploidy alterations on liver function, metabolism, or regeneration, mice with more polyploid hepatocytes suppressed tumorigenesis and mice with more diploid hepatocytes accelerated tumorigenesis in mutagen- and high-fat-induced models. Mechanistically, the diploid state was more susceptible to Cas9-mediated tumor-suppressor loss but was similarly susceptible to MYC oncogene activation, indicating that polyploidy differentially protected the liver from distinct genomic aberrations. This suggests that polyploidy evolved in part to prevent malignant outcomes of liver injury.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anln; E2f8; cytokinesis; hepatocellular carcinoma; liver cancer; mouse model; polyploidy

Mesh:

Substances:

Year:  2018        PMID: 29429824      PMCID: PMC5828993          DOI: 10.1016/j.devcel.2018.01.010

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  65 in total

Review 1.  The advantages and disadvantages of being polyploid.

Authors:  Luca Comai
Journal:  Nat Rev Genet       Date:  2005-11       Impact factor: 53.242

Review 2.  Polyploidization in liver tissue.

Authors:  Géraldine Gentric; Chantal Desdouets
Journal:  Am J Pathol       Date:  2013-10-17       Impact factor: 4.307

3.  Knockdown of Anillin Actin Binding Protein Blocks Cytokinesis in Hepatocytes and Reduces Liver Tumor Development in Mice Without Affecting Regeneration.

Authors:  Shuyuan Zhang; Liem H Nguyen; Kejin Zhou; Ho-Chou Tu; Alfica Sehgal; Ibrahim Nassour; Lin Li; Purva Gopal; Joshua Goodman; Amit G Singal; Adam Yopp; Yu Zhang; Daniel J Siegwart; Hao Zhu
Journal:  Gastroenterology       Date:  2017-12-21       Impact factor: 22.682

4.  Liver-specific pRB loss results in ectopic cell cycle entry and aberrant ploidy.

Authors:  Christopher N Mayhew; Emily E Bosco; Sejal R Fox; Tomohisa Okaya; Pheruza Tarapore; Sandy J Schwemberger; George F Babcock; Alex B Lentsch; Kenji Fukasawa; Erik S Knudsen
Journal:  Cancer Res       Date:  2005-06-01       Impact factor: 12.701

5.  Telomere-driven tetraploidization occurs in human cells undergoing crisis and promotes transformation of mouse cells.

Authors:  Teresa Davoli; Titia de Lange
Journal:  Cancer Cell       Date:  2012-06-12       Impact factor: 31.743

Review 6.  Aneuploidy, polyploidy and ploidy reversal in the liver.

Authors:  Andrew W Duncan
Journal:  Semin Cell Dev Biol       Date:  2013-01-16       Impact factor: 7.727

7.  p53 regulates a mitotic transcription program and determines ploidy in normal mouse liver.

Authors:  Svitlana Kurinna; Sabrina A Stratton; Zeynep Coban; Jill M Schumacher; Markus Grompe; Andrew W Duncan; Michelle Craig Barton
Journal:  Hepatology       Date:  2013-02-15       Impact factor: 17.425

8.  Chromosome missegregation rate predicts whether aneuploidy will promote or suppress tumors.

Authors:  Alain D Silk; Lauren M Zasadil; Andrew J Holland; Benjamin Vitre; Don W Cleveland; Beth A Weaver
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-16       Impact factor: 11.205

9.  A rapid and scalable system for studying gene function in mice using conditional RNA interference.

Authors:  Prem K Premsrirut; Lukas E Dow; Sang Yong Kim; Matthew Camiolo; Colin D Malone; Cornelius Miething; Claudio Scuoppo; Johannes Zuber; Ross A Dickins; Scott C Kogan; Kenneth R Shroyer; Raffaella Sordella; Gregory J Hannon; Scott W Lowe
Journal:  Cell       Date:  2011-04-01       Impact factor: 41.582

10.  The mutational landscapes of genetic and chemical models of Kras-driven lung cancer.

Authors:  Peter M K Westcott; Kyle D Halliwill; Minh D To; Mamunur Rashid; Alistair G Rust; Thomas M Keane; Reyno Delrosario; Kuang-Yu Jen; Kay E Gurley; Christopher J Kemp; Erik Fredlund; David A Quigley; David J Adams; Allan Balmain
Journal:  Nature       Date:  2014-11-02       Impact factor: 49.962

View more
  51 in total

Review 1.  Solving the Polyploid Mystery in Health and Disease.

Authors:  K J Gjelsvik; R Besen-McNally; V P Losick
Journal:  Trends Genet       Date:  2018-11-21       Impact factor: 11.639

2.  Polyploid Hepatocytes Facilitate Adaptation and Regeneration to Chronic Liver Injury.

Authors:  Patrick D Wilkinson; Frances Alencastro; Evan R Delgado; Madeleine P Leek; Matthew P Weirich; P Anthony Otero; Nairita Roy; Whitney K Brown; Michael Oertel; Andrew W Duncan
Journal:  Am J Pathol       Date:  2019-03-28       Impact factor: 4.307

3.  Knockdown of Anillin Actin Binding Protein Blocks Cytokinesis in Hepatocytes and Reduces Liver Tumor Development in Mice Without Affecting Regeneration.

Authors:  Shuyuan Zhang; Liem H Nguyen; Kejin Zhou; Ho-Chou Tu; Alfica Sehgal; Ibrahim Nassour; Lin Li; Purva Gopal; Joshua Goodman; Amit G Singal; Adam Yopp; Yu Zhang; Daniel J Siegwart; Hao Zhu
Journal:  Gastroenterology       Date:  2017-12-21       Impact factor: 22.682

Review 4.  Polyploidy: A Biological Force From Cells to Ecosystems.

Authors:  Donald T Fox; Douglas E Soltis; Pamela S Soltis; Tia-Lynn Ashman; Yves Van de Peer
Journal:  Trends Cell Biol       Date:  2020-07-06       Impact factor: 20.808

5.  Lipid-Modified Aminoglycosides for mRNA Delivery to the Liver.

Authors:  Xueliang Yu; Shuai Liu; Qiang Cheng; Tuo Wei; Sang Lee; Di Zhang; Daniel J Siegwart
Journal:  Adv Healthc Mater       Date:  2020-02-28       Impact factor: 9.933

6.  CDK1-PLK1/SGOL2/ANLN pathway mediating abnormal cell division in cell cycle may be a critical process in hepatocellular carcinoma.

Authors:  Ling Li; Kang Huang; Huijia Zhao; Binyao Chen; Qifa Ye; Jiang Yue
Journal:  Cell Cycle       Date:  2020-04-10       Impact factor: 4.534

7.  Theranostic dendrimer-based lipid nanoparticles containing PEGylated BODIPY dyes for tumor imaging and systemic mRNA delivery in vivo.

Authors:  Hu Xiong; Shuai Liu; Tuo Wei; Qiang Cheng; Daniel J Siegwart
Journal:  J Control Release       Date:  2020-07-03       Impact factor: 9.776

Review 8.  Hepatocyte ploidy and pathological mutations in hepatocellular carcinoma: impact on oncogenesis and therapeutics.

Authors:  Taiji Yamazoe; Taizo Mori; Sachiyo Yoshio; Tatsuya Kanto
Journal:  Glob Health Med       Date:  2020-10-31

Review 9.  The origins and functions of hepatic polyploidy.

Authors:  Shuyuan Zhang; Yu-Hsuan Lin; Branden Tarlow; Hao Zhu
Journal:  Cell Cycle       Date:  2019-05-26       Impact factor: 4.534

10.  The pro-oncogenic effect of the lncRNA H19 in the development of chronic inflammation-mediated hepatocellular carcinoma.

Authors:  Lika Gamaev; Lina Mizrahi; Tomer Friehmann; Nofar Rosenberg; Orit Pappo; Devorah Olam; Evelyne Zeira; Keren Bahar Halpern; Stefano Caruso; Jessica Zucman-Rossi; Jonathan H Axelrod; Eithan Galun; Daniel S Goldenberg
Journal:  Oncogene       Date:  2020-10-22       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.